Clarence Machado
Chairman at ADVERUM BIOTECHNOLOGIES, INC.
Net worth: 302 706 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Hung | M | 66 |
Medivation, Inc. /Old/
Pro-Duct Health, Inc.
Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer
Medivation Neurology LLC
Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The company is based in San Francisco, CA.
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | 24 years |
Michael Sherman | M | 58 | 18 years | |
Dawn Svoronos | F | 70 | 11 years | |
Ian Mortimer | M | 48 | 11 years | |
Jennifer Jarrett | F | 53 |
Medivation, Inc. /Old/
| 8 years |
Michael Andriole | M | 51 | 7 years | |
Kathryn Falberg | F | 63 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 11 years |
Simon Pimstone | M | 56 | 28 years | |
Mina Kim | F | 50 | 2 years | |
Fred Middleton | M | 74 | 23 years | |
Laurent Fischer | M | 60 | 4 years | |
Terry Rosen | M | 65 | 9 years | |
Juan Jaen | M | 66 | 9 years | |
Dan Becker | M | 49 | 6 years | |
Eric Venker | M | 37 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 years |
Viwat Visuthikraisee | M | - |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | - |
Michelle LaSpaluto | F | - | 13 years | |
Peter Soparkar | M | 53 | 5 years | |
Martha Demski | F | 71 | 19 years | |
Alan Colowick | M | 61 | 7 years | |
Sandra Ramos-Alves | F | - | 2 years | |
George Bickerstaff | M | 68 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Scott Sukenick | M | 46 | 7 years | |
Roy W. Ware | M | - | 17 years | |
Jim Momtazee | M | - | 3 years | |
Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 years |
Anand Reddi | M | 42 | - | |
Rabia Ozden | M | 56 | 2 years | |
Soo Hong | F | 52 | 2 years | |
Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
Elizabeth Garofalo | M | 66 | 3 years | |
Matthew Gline | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 years |
Lisa Decker | M | 55 | 1 years | |
Scott Lipman | M | - | 4 years | |
Richard Pulik | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Adam Levy | M | - | 3 years | |
Victoria Vakiener | F | 60 | 3 years | |
Alexander Azoy | M | 48 | 4 years | |
David Jakeman | M | 47 | 15 years | |
Sherry Aulin | F | 40 | 13 years | |
Heikki Jouttijärvi | M | - | 4 years | |
Scott Whitcup | M | 64 | 4 years | |
Jodi Regts | F | - | 9 years | |
Andrea DiFabio | F | 55 | 2 years | |
C. Nicholson | M | 68 | 1 years | |
Linda Rubinstein | F | 58 | 2 years | |
Armando Anido | M | 66 | 5 years | |
Bruce Cozadd | M | 60 | 2 years | |
David Hastings | M | 62 | 9 years | |
Mohammad Azab | M | 68 | 21 years | |
Yasunori Kaneko | M | 69 | 9 years | |
Gary Patou | M | 65 | 20 years | |
Dan Gold | M | 56 | 4 years | |
Jim Scopa | M | 65 | 5 years | |
John Rakow | M | 67 | 3 years | |
Andrew Perlman | M | 76 | 4 years | |
Steven Gannon | M | 62 | 9 years | |
Nicole Lambert | F | 50 | 3 years | |
Gil Labrucherie | M | 52 | 2 years | |
Mark Lupher | M | 53 | 5 years | |
Reed Tuckson | M | 73 | 3 years | |
Michael Alrutz | M | 54 | 12 years | |
Pratik Multani | M | 57 | 4 years | |
Pek Yee Lum | M | - |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | - |
Antoni Ribas | M | 57 | 5 years | |
David Lacey | M | 71 | 4 years | |
Ilan Oren | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Robert Goeltz | M | 51 | 4 years | |
Robert Meyer | M | 65 | 6 years | |
Shephard Mpofu | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Leone Patterson | F | 61 | 5 years | |
Yi Shan Li | M | 59 | 6 years | |
Paul Cleveland | M | 67 | 4 years | |
Pavan Cheruvu | M | 42 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | 4 years |
Jing Rong Cui | M | 60 | 7 years | |
Marion McCourt | F | 64 | 2 years | |
Frank Holler | M | 67 | 25 years | |
Amber Salzman | M | 62 | 2 years | |
Michael Hayden | M | 72 | 26 years | |
Shao Lee Lin | M | 57 | 5 years | |
Yves Joseph Ribeill | M | 64 | 17 years | |
Gregory Bailey | M | 68 |
Medivation, Inc. /Old/
| 7 years |
Timothy J. Wollaeger | M | 80 | 16 years | |
Simeon George | M | 47 | 11 years | |
Daniel Levangie | M | 73 |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | 5 years |
Jason Barker | M | 54 | 1 years | |
Jennifer J. Rhodes | F | 53 | 3 years | |
Jennifer Cheng | M | 51 | 4 years | |
Steven Schwartz | M | 62 | 11 years | |
Garry Nicholson | M | 69 | 2 years | |
Mohammad Hirmand | M | 54 | 14 years | |
Thomas S. Templeman | M | 64 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Medivation, Inc. /Old/
| 3 years |
David Southwell | M | 63 |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | 4 years |
John C. Aplin | M | 78 | 15 years | |
Christopher Chai | M | 58 | 7 years | |
M. Berrey | M | 57 | 7 years | |
Philip Low | M | 76 | 23 years | |
Tony Vernon | M | 68 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY.
Medivation, Inc. /Old/
| 1 years |
Brian Baker | M | 57 | 4 years | |
Christopher J. DeRespino | M | 43 | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 87 | 87.00% |
Canada | 13 | 13.00% |
United Kingdom | 11 | 11.00% |
Switzerland | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Clarence Machado
- Personal Network